Matthew Plunkett
2015 - CTI BioPharma
In 2015, Matthew Plunkett earned a total compensation of $2.7M as Executive Vice President, Chief Business Officer at CTI BioPharma, a 32% increase compared to previous year.
Compensation breakdown
| Bonus | $81,250 |
|---|---|
| Option Awards | $1,152,060 |
| Salary | $325,000 |
| Stock Awards | $1,126,322 |
| Other | $9,137 |
| Total | $2,693,769 |
Plunkett received $1.2M in option awards, accounting for 43% of the total pay in 2015.
Plunkett also received $81.3K in bonus, $325K in salary, $1.1M in stock awards and $9.1K in other compensation.
Rankings
In 2015, Matthew Plunkett's compensation ranked 3,562nd out of 13,638 executives tracked by ExecPay. In other words, Plunkett earned more than 73.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,562 out of 13,638 | 74th |
Division Manufacturing | 1,298 out of 5,190 | 75th |
Major group Chemicals And Allied Products | 471 out of 1,854 | 75th |
Industry group Drugs | 377 out of 1,528 | 75th |
Industry Pharmaceutical Preparations | 296 out of 1,182 | 75th |
Source: SEC filing on March 28, 2017.
Plunkett's colleagues
We found four more compensation records of executives who worked with Matthew Plunkett at CTI BioPharma in 2015.